EP3353322
PROGNOSTIC METHOD FOR DETERMINING THE RISK OF RELAPSE IN RENAL CANCER PATIENTS WITH A CLEAR CELL TYPE OF RENAL CARCINOMA, STAGES I AND II, AND KIT FOR SAME
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
23.9.2016EP published:
15.4.2020EP application number:
16774644.5
EPO information:
European Patent Register
Max expiry date:
22.9.2036
Title:
PROGNOSTIC METHOD FOR DETERMINING THE RISK OF RELAPSE IN RENAL CANCER PATIENTS WITH A CLEAR CELL TYPE OF RENAL CARCINOMA, STAGES I AND II, AND KIT FOR SAME
Timeline
Today
23.9.2016EP application
15.4.2020EP Publication
Owner
Name:
Fundación para la Investigación Biomedica del Hospital 12 de OctubreAddress:
Avda. de Córdoba s/n CAA 6th Floor Planta Bloque, 28041 Madrid, ES
Name:
Fundación Para la Investigación Biomédica del Hospital Universitario de la PazAddress:
Paseo de la Castellana 261 Edificio Norte (Antigua Escuela de Enfermeras) 4ª Planta, 28046 Madrid, ES
Inventor
Name:
MIRANDA UTRERA, NataliaAddress:
28041 Madrid, ES
Name:
VILLACAMPA AUBÁ, FelipeAddress:
28041 Madrid, ES
Name:
CASTELLANO, DanielAddress:
28041 Madrid, ES
Name:
FRESNO VARA, Juan ÁngelAddress:
28041 Madrid, ES
Name:
GÁMEZ POZO, AngeloAddress:
28041 Madrid, ES
Priority
Number:
201531360Date:
23.9.2015Country:
ES
Classification
Categories:
C12Q 1/68